Predicting survival in prostate cancer: The role of quality of life assessment

Supportive Care in Cancer

Volumn 20, Issue 6, 2012, Pages 1267-1274

  Braun, Donald P ^a,b   Gupta, Digant ^a   Staren, Edgar D ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

^b NONE   (United States)

Author keywords

Prognosis; Prostate cancer; Quality of life

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CONSTIPATION; DYSPNEA; EMOTIONALITY; EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; FATIGUE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; NAUSEA; OVERALL SURVIVAL; PAIN; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SOCIAL ASPECT; SURVIVAL PREDICTION; VOMITING;

EID: 84863988508     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1213-x     Document Type: Article

References (51)

1. http://www.cancer.gov/cancertopics/types/prostate. Retrieved February 17, 2011
2. Brawley OW, Barnes S (2001) The epidemiology of prostate cancer in the United States. Semin Oncol Nurs 17:72-77
3. Chodak G (2006) Prostate cancer: epidemiology, screening, and biomarkers. Rev Urol 8(Suppl 2):S3-S8
4. Damber JE (1998) Prostate cancer: epidemiology and risk factors. Curr Opin Urol 8:375-380
5. Gronberg H (2003) Prostate cancer epidemiology. Lancet 361:859-864 (Pubitemid 36331852)
6. Hsing AW, Chokkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388-1413 (Pubitemid 43253429)
7. Wilt TJ (2003) Prostate cancer: epidemiology and screening. Rev Urol 5(Suppl 6):S3-S9
8. Sartor O (2002) Endpoints in prostate cancer clinical trials. Urology 60:101-107
9. Collette L et al (2004) Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 22:3877-3885 (Pubitemid 41079868)
10. Halabi S et al (2008) Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol 26:2544-2549
11. Lis CG, Gupta D, Grutsch JF (2008) Patient satisfaction with health-related quality of life: implications for prognosis in prostate cancer. Clin Genitourin Canc 6:91-96
12. Sullivan PW, Nelson JB, Mulani PM, Sleep D (2006) Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res 15:1297-1306 (Pubitemid 44673606)
13. Blazeby JM, Brookes ST, Alderson D (2000) Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 87:362-373
14. Coates A et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10:1833-1838 (Pubitemid 23064193)
15. Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Canc 33:1025-1030 (Pubitemid 27310776)
16. Coates AS et al (2000) Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18:3768-3774
17. Dancey J et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 6:151-158 (Pubitemid 27207280)
18. Dharma-Wardene M et al (2004) Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13:1209-1216 (Pubitemid 39157332)
19. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14:171-175 (Pubitemid 26020010)
20. Efficace F et al (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Canc 40:1021-1030 (Pubitemid 38496258)
21. Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF (2004) Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100:425-432 (Pubitemid 38063655)
22. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY (2004) Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58:1394-1404
23. Kramer JA et al (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Canc 36:1498-1506 (Pubitemid 30619002)
24. Langendijk H et al (2000) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable nonsmall cell lung carcinoma treated with radiotherapy. Radiother Oncol 55:19-25 (Pubitemid 30219430)
25. Luoma ML et al (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Canc 39:1370-1376
26. Maisey NR et al (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Canc 38:1351-1357 (Pubitemid 34686846)
27. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Canc 31:233-240 (Pubitemid 32107019)
28. Roychowdhury DF, Hayden A, Liepa AM (2003) Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 21:673-678 (Pubitemid 46621902)
29. Tamburini M, Brunelli C, Rosso S, Ventafridda V (1996) Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manag 11:32-41 (Pubitemid 26046083)
30. Herndon JE et al (1999) Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 85:333-340
31. Blazeby JM et al (2006) Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 24:3178-3186 (Pubitemid 46646225)
32. Davies N (2009) Measuring health-related quality of life in cancer patients. Nurs Stand 23:42-49
33. Halyard MY, Ferrans CE (2008) Quality-of-life assessment for routine oncology clinical practice. J Support Oncol 6:221-229, 233 (Pubitemid 351836609)
34. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related qualityof-life scores. J Clin Oncol 16:139-144 (Pubitemid 28041591)
35. Aaronson NK et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Canc Inst 85:365-376 (Pubitemid 23073154)
36. Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441-450 (Pubitemid 27223274)
37. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13:1249-1254
38. Braeckman J, Michielsen D (2007) Prognostic factors in prostate cancer. Recent Results Canc Res 175:25-32
39. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640-650 (Pubitemid 37013308)
40. Curt GA et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353-360
41. Lesage P, Portenoy RK (2002) Management of fatigue in the cancer patient. Oncology (Williston Park) 16:373-378, 381
42. Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1-10 (Pubitemid 29102450)
43. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786-1801 (Pubitemid 37310220)
44. Stone P, Richards M, Hardy J (1998) Fatigue in patients with cancer. Eur J Canc 34:1670-1676 (Pubitemid 28474217)
45. Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5(Suppl 2):9-12 (Pubitemid 30413709)
46. Ahlberg K, Ekman T, Wallgren A, Gaston-Johansson F (2004) Fatigue, psychological distress, coping and quality of life in patients with uterine cancer. J Adv Nurs 45:205-213 (Pubitemid 38142731)
47. Bower JE et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743-753 (Pubitemid 30106604)
48. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689-1696 (Pubitemid 28234711)
49. Jacobsen PB et al (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manag 18:233-242 (Pubitemid 29469701)
50. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y (2002) Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manag 23:417-423 (Pubitemid 34463010)
51. Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Canc 6:101-108 (Pubitemid 28110532)